首页> 美国卫生研究院文献>BioMed Research International >Progenitors for the Corneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma
【2h】

Progenitors for the Corneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma

机译:角膜内皮和小梁网的祖细胞:个性化干细胞治疗角膜内皮病和青光眼的潜在来源

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several adult stem cell types have been found in different parts of the eye, including the corneal epithelium, conjunctiva, and retina. In addition to these, there have been accumulating evidence that some stem-like cells reside in the transition area between the peripheral corneal endothelium (CE) and the anterior nonfiltering portion of the trabecular meshwork (TM), which is known as the Schwalbe's Ring region. These stem/progenitor cells may supply new cells for the CE and TM. In fact, the CE and TM share certain similarities in terms of their embryonic origin and proliferative capacity in vivo. In this paper, we discuss the putative stem cell source which has the potential for replacement of lost and nonfunctional cells in CE diseases and glaucoma. The future development of personalized stem cell therapies for the CE and TM may reduce the requirement of corneal grafts and surgical treatments in glaucoma.
机译:在眼睛的不同部位发现了几种成人干细胞类型,包括角膜上皮,结膜和视网膜。除此之外,已有越来越多的证据表明,一些干细胞样细胞位于周围角膜内皮(CE)和小梁网(TM)的前非滤过部分之间的过渡区域,该区域称为Schwalbe环区。这些干/祖细胞可能会为CE和TM提供新的细胞。实际上,CE和TM在胚胎起源和体内增殖能力方面具有某些相似性。在本文中,我们讨论了推定的干细胞来源,该来源具有替代CE疾病和青光眼中丢失和失去功能的细胞的潜力。 CE和TM个性化干细胞疗法的未来发展可能会减少青光眼中角膜移植物和外科治疗的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号